CoChat

A novel role of the antidepressant paroxetine in inhibiting neuronal Kv7/M channels to enhance neuronal excitability

Open access
Shi, Huan, Li, Qinqin, Hu, Fang, Liu, Yani, Wang, KeWei · 2025 · Translational Psychiatry

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Abstract

The voltage-gated Kv7/KCNQ/M potassium channels exert inhibitory control over neuronal membrane excitability. The reduction of Kv7 channel function can improve neuronal excitability that defines the fundamental mechanism of learning and memory. This suggests that pharmacological inhibition of Kv7 channels may present a therapeutic strategy for cognitive improvement. Paroxetine, a selective serotonin reuptake inhibitor, is widely used in the treatment of various types of depression with reported improvements in memory and attention. However, the exact mechanism underlying cognitive improvement by paroxetine remains poorly understood. In this study, we demonstrate that paroxetine inhibits whole-cell Kv7.2/Kv7.3 channel currents in a concentration-dependent manner with an IC 50 of 3.6 ± 0.2 μΜ. In single-channel recording assay, paroxetine significantly reduces the open probability of Kv7.2/Kv7.3 channels. Moreover, paroxetine exhibits an inhibition of the native M-current and an increase in the firing of action potentials in hippocampal neurons. Taken together, our findings unveil a novel role of the antidepressant paroxetine in inhibiting M-current, providing insights into its pharmacological effects on cognition enhancement.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41398-025-03291-w

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Concentration-dependent inhibition of Kv7.2/Kv7.3 currents by paroxetine. A Left panel, representative Kv7.2/Kv7.3 current traces elicited by depolarizing potential at 0 mV before and after application of paroxetine (3 μM) or positive control XE991 (3 μM). The dotted line represents zero current level; Right panel, summary for normalized current from left panel (n = 5), paired t-test, ***P < 0.001. B Left panel, concentration-dependent inhibition of Kv7.2/Kv7.3 currents by paroxetine. Representative current traces from each concentration of paroxetine are shown in the inset; Right panel, data from the left panel were fitted with Logistic function and IC50 of 3.6 ± 0.2 μΜ was obtained (n = 5). C Left panels, representative current traces from Kv7.2/Kv7.3 channels in response to depolarizing voltage steps from −110–30 mV with an increment of 10 mV followed by a pulse at 0 mV in the absence (left panel) and presence (middle panel) of paroxetine; Right panel, activation curves of Kv7.2/Kv7.3 currents in the absence or presence of paroxetine measured at the beginning of the 0 mV and fitted with Boltzmann function (n = 8). D Superimposed activation traces generated at 0 mV (left panel) and deactivation traces at −120 mV (middle panel) before and after paroxetine (3 μΜ). The current traces from paroxetine were scaled up to the same current amplitude of the control (blue dotted line); Right panel, summary of the effect of paroxetine on activation and deactivation time constants of Kv7.2/Kv7.3 fitted with a single exponential function (n = 5), paired t-test, *P < 0.05. All data were expressed as the mean±SEM.
Fig. 1 Concentration-dependent inhibition of Kv7.2/Kv7.3 currents by paroxetine. A Left panel, representative Kv7.2/Kv7.3 current traces elicited by depolarizing potential at 0 mV before and after application of paroxetine (3 μM) or positive control XE991 (3 μM). The dotted line represents zero current level; Right panel, summary for normalized current from left panel (n = 5), paired t-test, ***P < 0.001. B Left panel, concentration-dependent inhibition of Kv7.2/Kv7.3 currents by paroxetine. Representative current traces from each concentration of paroxetine are shown in the inset; Right panel, data from the left panel were fitted with Logistic function and IC50 of 3.6 ± 0.2 μΜ was obtained (n = 5). C Left panels, representative current traces from Kv7.2/Kv7.3 channels in response to depolarizing voltage steps from −110–30 mV with an increment of 10 mV followed by a pulse at 0 mV in the absence (left panel) and presence (middle panel) of paroxetine; Right panel, activation curves of Kv7.2/Kv7.3 currents in the absence or presence of paroxetine measured at the beginning of the 0 mV and fitted with Boltzmann function (n = 8). D Superimposed activation traces generated at 0 mV (left panel) and deactivation traces at −120 mV (middle panel) before and after paroxetine (3 μΜ). The current traces from paroxetine were scaled up to the same current amplitude of the control (blue dotted line); Right panel, summary of the effect of paroxetine on activation and deactivation time constants of Kv7.2/Kv7.3 fitted with a single exponential function (n = 5), paired t-test, *P < 0.05. All data were expressed as the mean±SEM.CC BY-NC-ND · PubMed Central
Fig. 2 Reduction of Kv7.2/Kv7.3 single channel open probability by paroxetine. A Representative single-channel (cell-attached) current traces recorded at 0 mV with or without 3 μM paroxetine. Letters O and C indicate channel open state (O) and closed state (C), respectively. B All-point amplitude histograms of single-channel currents in panel A. C Summary for effects of paroxetine on Kv7.2/Kv7.3 single-channel open probability and conductance. Paired t-test, ***P < 0.001; ns, no signification; n = 5.
Fig. 2 Reduction of Kv7.2/Kv7.3 single channel open probability by paroxetine. A Representative single-channel (cell-attached) current traces recorded at 0 mV with or without 3 μM paroxetine. Letters O and C indicate channel open state (O) and closed state (C), respectively. B All-point amplitude histograms of single-channel currents in panel A. C Summary for effects of paroxetine on Kv7.2/Kv7.3 single-channel open probability and conductance. Paired t-test, ***P < 0.001; ns, no signification; n = 5.CC BY-NC-ND · PubMed Central
Fig. 3 Concentration-dependent inhibition of Kv7.2 currents by paroxetine. A Left panel, Representative current traces for concentration-dependent inhibition of Kv7.2 by paroxetine. The dotted line represents zero current level; Right panel, data from the left panel were fitted with Logistic function and IC50 of 12.3 ± 6.5 μM was obtained (n = 9). B Representative current traces of Kv7.2 channels in response to depolarizing voltage steps followed by a pulse at 0 mV in the absence (left panel) and presence (middle panel) of paroxetine; Right panel, activation curves of Kv7.2 in the absence or presence of paroxetine measured at the beginning of the 0 mV and fitted with Boltzmann function (n = 6). C Superimposed activation traces generated at 0 mV (left panel) and deactivation traces at −120 mV (middle panel) before and after paroxetine (10 μΜ). The current traces from paroxetine were scaled up to the same current amplitude of the control (blue dotted line); Right panel, summary of the effect of paroxetine on activation and deactivation time constants of Kv7.2 fitted with a single exponential function (n = 6). All data were expressed as the mean±SEM. Paired t-test, *P < 0.05.
Fig. 3 Concentration-dependent inhibition of Kv7.2 currents by paroxetine. A Left panel, Representative current traces for concentration-dependent inhibition of Kv7.2 by paroxetine. The dotted line represents zero current level; Right panel, data from the left panel were fitted with Logistic function and IC50 of 12.3 ± 6.5 μM was obtained (n = 9). B Representative current traces of Kv7.2 channels in response to depolarizing voltage steps followed by a pulse at 0 mV in the absence (left panel) and presence (middle panel) of paroxetine; Right panel, activation curves of Kv7.2 in the absence or presence of paroxetine measured at the beginning of the 0 mV and fitted with Boltzmann function (n = 6). C Superimposed activation traces generated at 0 mV (left panel) and deactivation traces at −120 mV (middle panel) before and after paroxetine (10 μΜ). The current traces from paroxetine were scaled up to the same current amplitude of the control (blue dotted line); Right panel, summary of the effect of paroxetine on activation and deactivation time constants of Kv7.2 fitted with a single exponential function (n = 6). All data were expressed as the mean±SEM. Paired t-test, *P < 0.05.CC BY-NC-ND · PubMed Central
Fig. 4 Reduction of Kv7.2 single channel open probability by paroxetine. A Representative single-channel (cell-attached) current traces recorded at 0 mV with or without 10 μM paroxetine. B All-point amplitude histograms of single-channel currents in panel A. C Representative single-channel current traces before and after application of XE991 (3 μΜ). D Left and middle panels, all-point amplitude histograms of single-channel currents in panel C. Right panel, summary for effects of paroxetine and XE991 on Kv7.2 single-channel open probability and conductance. Paired t-test, ***P < 0.001, n = 4–5.
Fig. 4 Reduction of Kv7.2 single channel open probability by paroxetine. A Representative single-channel (cell-attached) current traces recorded at 0 mV with or without 10 μM paroxetine. B All-point amplitude histograms of single-channel currents in panel A. C Representative single-channel current traces before and after application of XE991 (3 μΜ). D Left and middle panels, all-point amplitude histograms of single-channel currents in panel C. Right panel, summary for effects of paroxetine and XE991 on Kv7.2 single-channel open probability and conductance. Paired t-test, ***P < 0.001, n = 4–5.CC BY-NC-ND · PubMed Central
Fig. 5 Concentration-dependent inhibition of other Kv7 subtypes by paroxetine. A–C, Representative current traces of Kv7.1 (A), Kv7.4 (B), Kv7.5 (C) expressed in HEK293T cells before and after application of different concentrations of paroxetine. The dotted lines represent zero current level. D Concentration-dependent inhibition effect of paroxetine on Kv7 channels and fitted with Logistic function (n = 5–10).
Fig. 5 Concentration-dependent inhibition of other Kv7 subtypes by paroxetine. A–C, Representative current traces of Kv7.1 (A), Kv7.4 (B), Kv7.5 (C) expressed in HEK293T cells before and after application of different concentrations of paroxetine. The dotted lines represent zero current level. D Concentration-dependent inhibition effect of paroxetine on Kv7 channels and fitted with Logistic function (n = 5–10).CC BY-NC-ND · PubMed Central
Fig. 6 The effects of paroxetine on the voltage-dependent activation of other Kv7 channels. A–C, Left and middle panels show a family of voltage-dependent currents of each Kv7 channel in the absence (left panels) and presence (middle panels) of paroxetine. The dotted lines represent zero current level; Right panels, activation curves of Kv7 channels fitted by Boltzmann function without or with paroxetine (n = 6–7).
Fig. 6 The effects of paroxetine on the voltage-dependent activation of other Kv7 channels. A–C, Left and middle panels show a family of voltage-dependent currents of each Kv7 channel in the absence (left panels) and presence (middle panels) of paroxetine. The dotted lines represent zero current level; Right panels, activation curves of Kv7 channels fitted by Boltzmann function without or with paroxetine (n = 6–7).CC BY-NC-ND · PubMed Central
Fig. 7 Inhibition of native M-current and increase of firings in hippocampal neurons by paroxetine. A Left panel, representative M-current traces without or with 3 μM XE991, 10 μM paroxetine and 10 μM RTG recorded in hippocampal neurons. The dotted line represents the zero current level; Right panel, the inhibition effect of paroxetine (3 μM, n = 5; 10 μM, n = 16) and XE991 (3 μM, n = 10) on M-current measured at −20 mV. One-way ANOVA followed by Tukey test, ***P < 0.001. B Left panel, depolarization shift of resting membrane potentials (RMP) of hippocampal neurons by paroxetine (3 μM, n = 6; 10 μM, n = 21). Paired t-test, **P < 0.01, ***P < 0.001. Right panel, statistics for changes of RMP with paroxetine (3 μM and 10 μM), XE991 (1 μM and 3 μM) and RTG (10 μM). C Representative action potential traces before and after application of paroxetine (3 μM and 10 μM) and XE991 (3 μM). D Summary for increased firings by paroxetine (3 μM, n = 5; 10 μΜ, n = 7; left) and 3 μM XE991 (n = 6; right) in hippocampal neurons. Paired t-test, *P < 0.05, **P < 0.01, ***P < 0.001.
Fig. 7 Inhibition of native M-current and increase of firings in hippocampal neurons by paroxetine. A Left panel, representative M-current traces without or with 3 μM XE991, 10 μM paroxetine and 10 μM RTG recorded in hippocampal neurons. The dotted line represents the zero current level; Right panel, the inhibition effect of paroxetine (3 μM, n = 5; 10 μM, n = 16) and XE991 (3 μM, n = 10) on M-current measured at −20 mV. One-way ANOVA followed by Tukey test, ***P < 0.001. B Left panel, depolarization shift of resting membrane potentials (RMP) of hippocampal neurons by paroxetine (3 μM, n = 6; 10 μM, n = 21). Paired t-test, **P < 0.01, ***P < 0.001. Right panel, statistics for changes of RMP with paroxetine (3 μM and 10 μM), XE991 (1 μM and 3 μM) and RTG (10 μM). C Representative action potential traces before and after application of paroxetine (3 μM and 10 μM) and XE991 (3 μM). D Summary for increased firings by paroxetine (3 μM, n = 5; 10 μΜ, n = 7; left) and 3 μM XE991 (n = 6; right) in hippocampal neurons. Paired t-test, *P < 0.05, **P < 0.01, ***P < 0.001.CC BY-NC-ND · PubMed Central
Fig. 8 The docking results of paroxetine to Kv7.2. A Side (left) and top (right) views of the predicted pocket of paroxetine binding to Kv7.2. B Overview of paroxetine binding to pocket and its zoom-in view of the binding pocket formed by residues F100 (S1), D212 (S4) and Y237 (S5, Adjacent α-subunit), the energy of amino acid residues in binding pocket is shown in the inset. C Left panels, representative current traces for concentration-dependent inhibition of D212A Kv7.2 and D212A Kv7.2/Kv7.3 by paroxetine. The dotted lines represent zero current level; Right panel, right shift of concentration-dependent inhibition of D212A Kv7.2 and D212A Kv7.2/Kv7.3 mutant channels by paroxetine in different concentrations (n = 5–8). D Representative current traces of WT Kv7.2, W236A, F240A, L299A, F304A and F305A Kv7.2 channel expressed in HEK293T cells before and after application of 10 or 30 µM paroxetine and summary of normalized inhibition effect is shown in the bottom right (n = 3–6). The dotted lines represent the zero current level. One-way ANOVA followed by Tukey test, **P < 0.01, ns, no signification.
Fig. 8 The docking results of paroxetine to Kv7.2. A Side (left) and top (right) views of the predicted pocket of paroxetine binding to Kv7.2. B Overview of paroxetine binding to pocket and its zoom-in view of the binding pocket formed by residues F100 (S1), D212 (S4) and Y237 (S5, Adjacent α-subunit), the energy of amino acid residues in binding pocket is shown in the inset. C Left panels, representative current traces for concentration-dependent inhibition of D212A Kv7.2 and D212A Kv7.2/Kv7.3 by paroxetine. The dotted lines represent zero current level; Right panel, right shift of concentration-dependent inhibition of D212A Kv7.2 and D212A Kv7.2/Kv7.3 mutant channels by paroxetine in different concentrations (n = 5–8). D Representative current traces of WT Kv7.2, W236A, F240A, L299A, F304A and F305A Kv7.2 channel expressed in HEK293T cells before and after application of 10 or 30 µM paroxetine and summary of normalized inhibition effect is shown in the bottom right (n = 3–6). The dotted lines represent the zero current level. One-way ANOVA followed by Tukey test, **P < 0.01, ns, no signification.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Cited by

See all 4

Metadata

Authors
Shi, H., Li, Q., Hu, F., Liu, Y., & Wang, K.
Affiliations
Qingdao University (CN)
Corresponding author
  • Liu, Yani
  • Wang, KeWei
Venue
Translational Psychiatry
Published
2025-04-02
Volume
15
Issue
1
Pages
116-116
ISSN
2158-3188 (ISSN-L)
OpenAlex
W4409148507
Cited by
2
References
58
Citations by year
2026: 2
FWCI
0.60
Type
journal article
Language
en
Open access
Licence
Locations
  • Translational Psychiatry (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (81973299, 82104149)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
paroxetine, Kv7 potassium channels, Kv7.2, Kv7.3, M-current, neuronal excitability, hippocampal neurons, antidepressant mechanism, cognitive enhancement, selective serotonin reuptake inhibitors, open probability, action potential firing
MeSH terms
Action Potentials, Animals, Hippocampus, Humans, Neurons, Selective Serotonin Reuptake Inhibitors, Paroxetine, Patch-Clamp Techniques, Antidepressive Agents, Second-Generation, Rats, KCNQ2 Potassium Channel, KCNQ3 Potassium Channel

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A novel role of the antidepressant paroxetine in inhibiting neuronal Kv7/M channels to enhance neuronal excitability. https://app.cochat.ai/papers/10.1038/s41398-025-03291-w
The paper
Shi, H., Li, Q., Hu, F., Liu, Y., & Wang, K. (2025). A novel role of the antidepressant paroxetine in inhibiting neuronal Kv7/M channels to enhance neuronal excitability. Translational Psychiatry. https://doi.org/10.1038/s41398-025-03291-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.